Atlas Trials

PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery

Clinical trial NCT03218826 · COMPLETED

Trial details

NCT number
NCT03218826
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Breast CarcinomaAdvanced Malignant Solid NeoplasmAdvanced Prostate CarcinomaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8Anatomic Stage IIIC Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Castration-Resistant Prostate CarcinomaMetastatic Breast CarcinomaMetastatic Malignant Solid NeoplasmMetastatic Prostate Carcinoma
Start date
2018-09-24
Primary completion
2022-07-25
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.